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http://www.behavioralandbrainfunctions.com/content/8/1/37RESEARCH Open AccessIndividuals at risk for Alzheimer’s disease show
differential patterns of ERP brain activation
during odor identification
Charlie D Morgan1 and Claire Murphy1,2,3*Abstract
Background: Studies suggest that older adults at risk of developing Alzheimer’s disease may show olfactory
processing deficits before other signs of dementia appear.
Methods: We studied 60 healthy non-demented individuals, half of whom were positive for the genetic risk factor
the Apolipoprotein E ε4 allele, in three different age groups. Event-related potentials to visual and olfactory
identification tasks were recorded and analyzed for latency and amplitude differences, and plotted via
topographical maps.
Results: Varying patterns of brain activation were observed over the post-stimulus epoch for ε4- versus ε4+
individuals on topographical maps. Individuals with the ε4 allele demonstrated different ERP peak latencies during
identification of olfactory but not visual stimuli. High correct ApoE classification rates were obtained utilizing the
olfactory ERP.
Conclusions: Olfactory ERPs demonstrate functional decline in individuals at risk for Alzheimer’s disease at much
earlier ages than previously observed, suggesting the potential for pre-clinical detection of AD at very early stages.
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OlfactionAlzheimer’s disease is a neurologic disorder accompan-
ied by progressive memory loss, cognition loss and func-
tional decline [1]. The cause or causes of AD are not yet
known and definitive diagnosis can only be made via
postmortem autopsy or, while living, a brain biopsy. The
greatest risk factor for development of AD is advancing
age. Genetic research has confirmed that the ε4 allele of
the apolipoprotein E (ApoE) gene is the strongest gen-
etic risk factor for AD [2-5]. Inheritance of a single
ApoE ε4 variant increases a persons risk of developing
AD by a factor of three in men and four in women, and
having two copies of the ε4 allele increases risk up to
15-fold compared to persons without the ε4 variant* Correspondence: cmurphy@sciences.sdsu.edu
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distribution, and reproduction in any medium[6,7]. Presence of the ε4 allele increases the risk but does
not guarantee future development of AD [8].
Studies have found olfactory dysfunction in AD in-
cluding impairment in olfactory threshold sensitivity,
odor identification, odor recognition memory, remote
memory for odors, and odor fluency for review see [9].
Regions of the brain involved in the processing of olfac-
tory information, such as the entorhinal cortex, prepiri-
form cortex, and the anterior olfactory nucleus show
increased neuritic plaques and neurofibrillary tangles in
AD, as well as cell loss, granulovacuolar degeneration
and tangles in the olfactory bulb [4,10-15]. The neuro-
pathological changes associated with AD have been
shown to affect the primary regions of the brain involved
in olfaction but have less effect on other primary sensory
areas [16]. Greater hippocampal atrophy has been
reported in non-demented ε4+ individuals compared to
ε4- controls [17]. Studies of persons with the ε4 allele
have also demonstrated olfactory deficits in odorCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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[20], as well as odor recognition memory [21]. Odor
identification appears to be particularly sensitive to cog-
nitive changes associated with dementia. Correct classifi-
cation rates of 100% have been obtained between
persons at risk for AD from controls utilizing an odor
identification test [22]. ε4+ individuals demonstrate sig-
nificantly poorer odor identification than ε4- nondemen-
ted older adults [18,23]. Odor identification abilities
declined more rapidly in ε4+ persons than ε4- persons
over a four year time period while during the same time
period there was no significant change in odor threshold,
picture identification, or DRS scores [24]. Odor identifi-
cation has been shown to be directly related to left hip-
pocampal volume and to AD pathology in the brain
[25,26]. Given that areas of the brain that process olfac-
tory information are some of the earliest affected in AD
and those at risk for AD, olfactory changes may be some
of the earliest signs of the disease in the preclinical
phase.
Neuroimaging studies have suggested a functional re-
cruitment hypothesis of age-related compensatory
changes where those with AD and those at risk for AD
utilize additional cognitive resources to bring memory-
related performance to normal levels [27-33]. Persons
with a positive family history (FH) of AD and those with
both FH and the ε4 allele had greater activation predom-
inantly in the bilateral posterior cingulate/precuneus, bi-
lateral temporoparietal junction, and bilateral prefrontal
cortex [34]. ApoE+ individuals produced greater brain
activation in the bilateral fusiform gyri, right superior
parietal cortex, left pyramis/uvula, left middle frontal
gyrus, and medial frontal gyrus [29]. Similarly, partici-
pants diagnosed with Mild Cognitive Impairment or AD
demonstrate greater activation in the frontal areas of the
brain [35]. These studies suggest the potential for detec-
tion of AD and early preclinical stages using measures of
brain response.
Brain activity can be measured from the surface of the
scalp via the electroencephalogram and more specifically
the event-related potential (ERP), a measure that is ex-
quisitely sensitive to the timing of the brain’s response.
Olfactory event-related potentials (OERPs) recorded in
relation to olfactory stimulation has demonstrated sensi-
tivity to subtle changes in olfactory functioning asso-
ciated with aging, disease, and ApoE status [36-45].
OERPs require odor stimulation via specially built olfact-
ometers which control the exact timing of stimulus
onset while avoiding simultaneous stimulation of other
sensory modalities such as stimulation of the trigeminal
system [39,46-49]. These olfactometers also warm and
humidify the air stream in order to prevent somatosen-
sory cues. Reaction times to odors vary based on the
stimulus and subject characteristics but range from 800-900 ms [50]. Neuronal recovery time of the olfactory
system is much longer than other sensory systems
[38,51,52]. Auditory and visual stimuli can be presented
every 2–3 seconds in ERP research without significant
adaptation [53-55] while in the olfactory system inter-
stimulus intervals of 30–45 seconds are required. This
slower neuronal recovery is partially due to olfactory re-
ceptor cells that rapidly adapt and slowly recover [56]
and partially due to habituation [52]. Given longer inter-
stimulus intervals in olfactory stimulation, fewer trials
are presented than in other systems in order to reduce
potential subject fatigue and loss of vigilance. A nar-
rower filter is also applied when processing the ERP data
to compensate for the smaller number of trials.
The early components of the OERP, the N1, P2, and
N2 are considered exogenous sensory components that
have been associated with odor threshold and odor iden-
tification [38,49,57]. The P3 component in general repre-
sents endogenous processing of a stimulus, reflecting
both stimulus classification speed and the ability to at-
tend to and evaluate a stimulus [58,59]. OERP P3 latency
correlates with neuropsychological tests that measure
memory and cognitive processing speed [60]. Several
studies have demonstrated increased OERP peak laten-
cies associated with aging [36,38,39,41,60]. Older males
produced significantly smaller OERP peak amplitudes
than older females when utilizing relatively short inter-
stimulus intervals, suggesting greater olfactory impair-
ments in males [38]. Studies of the OERP have further
documented olfactory deficits in AD [61], specifically
longer P2 and P3 latencies in AD patients compared to
controls. These latency measures also correlate signifi-
cantly with dementia status as measured by the Demen-
tia Rating Scale (DRS). Importantly, studies utilizing the
OERP with persons at risk for AD, due to the ApoE ε4 al-
lele, have also demonstrated differences. ε4+ non-
demented older adults produced significantly longer
OERP latencies than age-matched ε4- individuals [62].
Additionally, high sensitivity and specificity was obtained
in classifying ε4+ and ε4- individuals based on OERP la-
tency alone. Utilizing a cross-modal odor recognition
memory task differential brain activity was observed be-
tween ApoE groups, such that ε4- participants differed
from ε4+ participants in activation of the frontal elec-
trode sites, supporting the compensatory hypothesis [63].
This study examines OERPs in an odor identification
task compared to a picture identification task in three
separate age groups and in persons positive and negative
for the ε4 allele. We hypothesized that ε4+ individuals
would demonstrate differing topographical patterns of
brain activation compared to ε4- individuals as mea-
sured by the ERP. As in previous studies we also
hypothesized that ε4+ older adults would produce longer
OERP peak latencies than ε4- participants and that this
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with an odor threshold test and a traditional odor identi-
fication test (San Diego Odor Identification Test).
Methods and materials
Participants
Participants were 60 adults divided into three age groups,
Young Adults (10 M, 10F, Mean age = 22.8 years), Middle
Age Adults (10 M, 10F, Mean Age= 50.5), and Older
Adults (10 M, 10F, Mean age = 70.7). Half of each group
were positive for the ε4 allele. Table 1 presents demo-
graphic variables by age and ApoE groups. Participants
were recruited from the general community, from San
Diego State University, and from an ongoing subject pool
at the Lifespan Human Senses Laboratory. The research
was approved by IRBs at San Diego State University and
the University of California, San Diego and subjects gave
informed consent. All participants were screened for odor
sensitivity via odor threshold test and odor identification
test and any participants with threshold scores lower than
4, or odor identification scores less than 3, were excluded
from the study [22,64,65]. Participants were screened for
cognitive impairment using the Dementia Rating Scale,
and any participants scoring less than 133 were excluded
from the study [66]. Genetic DNA was obtained from each
subject using buccal swab of cheek cells and analyzed for
the APOE genotype at an offsite laboratory as described in
[67]. Data from 40 of these participants have previously
been published [68].
Procedure
San Diego Odor Identification Test (SDOIT)
The San Diego Odor Identification Test [22,57,69] con-
sists of 8 common household odors (e.g. chocolate, coffee)
presented in opaque jars. A set of 20 line drawings of the
8 odors and 14 distractors, presented in an array, were
placed in front of each participant. Participants smelled
the odors birhinically in random order and chose the odor
from the array of drawings. Verbalizing the name of the




Age (years) 22.6 (2.0) 50.7 (1.7)
Education (years) 14.7 (2.8) 14.9 (2.5)
Dementia Rating Scale Score (144 max) 142.4 (2.0) 139.8 (4.8)
Odor Threshold (dilution steps, 9 max) 7.4 (1.3) 6.7 (1.1)
Odor Identification Test (6 max) 5.9 (0.3) 4.9 (1.2)
OERP # Correctly Identified (28 max) 20.1 (4.3) 19.9 (6.1)
VERP # Correctly Identified (28 max) 21.2 (7.8) 26.0 (2.1)acceptable ways of responding. Total number correct of the
6 most commonly identified odors was used for analysis.
ERP stimulus presentation
Olfactory stimulation was performed via computer con-
trolled olfactometer incorporating designs of previous
olfactometers [39,46-49]. Odors were presented utilizing a
single stimulus paradigm for 200 msec and an interstimu-
lus interval (ISI) of 30 sec. Participants employed Velo-
pharyngeal closure to restrict breathing to the mouth and
thereby maintain a constant odorant flow rate [46,48,70].
Fourteen separate odors (banana, rose, cinnamon, peanut
butter, baby powder, mustard, chocolate, pine, lemon, or-
ange, vanilla, coffee, leather, wintergreen) were presented
twice each in pseudo-randomized order. Six of these odors
were chosen in order to replicate the most identifiable
odors from the San Diego Odor Identification Test
[22,57,69]. All odorants were undiluted and two drops of
each odorant were placed into the olfactometer before
each subject session. After each odor presentation the par-
ticipants were asked to identify the odor via button press
from a list of four written options presented on the com-
puter screen in front of them and their responses were
recorded electronically.
In a separate experimental session on the same testing
day, 28 visual line drawings of objects from the Boston
Naming Test [71] were presented on a computer screen in
front of the subject. Duration of each stimulus was 200 msec
with 30 sec ISIs. As in the olfactory identification task the
subjects were asked to identify each picture via button
press from a list of four written options on the computer
screen. Both olfactory and visual stimuli were presented
via Compumedics STIM2 software. Order of experimental
presentation, olfactory or visual, was randomized across
subjects so that some subjects received the visual experi-
ment first, and some the olfactory experiment first.
ERP recording
Olfactory and visual ERPs were obtained via Compume-
dics™ 64-electode AG/AG/CL sintered Quick-Cap andhavioral and performance data for each age and ApoE
ve ApoE Positive
Older Young Middle Older
71.2 (3.6) 23.1 (2.3) 50.2 (4.5) 70.2 (2.9)
16.1 (2.3) 14.9 (1.7) 15.2 (2.3) 14.8 (3.2)
140.3 (2.9) 140.3 (5.0) 140.8 (4.1) 141.5 (2.1)
6.3 (1.4) 7.3 (1.5) 6.8 (1.9) 4.4 (1.3)
5.0 (1.3) 5.6 (0.5) 4.8 (1.4) 4.3 (1.2)
18.7 (4.2) 18.3 (3.9) 15.5 (3.7) 17.6 (4.0)
25.7 (2.8) 22.7 (4.0) 22.1 (6.5) 26.3 (2.2)
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and recorded on computer hard disk via the Neuroscan
software package. Electrode impedances were kept below
10 kΩ. At the time of recording the EEG data were digi-
tized at 500 Hz through a 0.1 to 30 Hz bandpass filter.
Offline, the data were further filtered through a 0.1 to
6 Hz bandpass filter. Artifactual eyeblink activity was
recorded and corrected offline via the Neuroscan soft-
ware utilizing the Occular Artifact Reduction method
within the software. ERP trials that included other types
of artifactual activity were excluded using both auto-
mated exclusion (e.g. excluding all trials with voltage
ranges larger than 50 μV) and by visually inspecting
each trial prior to averaging . Ongoing EEG activity was
recorded throughout the experiment and then trials
epoched offline to 500 msec pre-stimulus and 1500 msec
post-stimulus. Baseline corrected trials were then aver-
aged. Peak amplitudes were measured from the pre-
stimulus baseline to maximum peak amplitude. Latency
windows from previous OERP studies [38,39] were used
as guidelines to identify peak components. Peaks were
picked blindly as to age, gender, and APOE status in
order to avoid experimenter bias.
Results
Demographics and screening measures
Table 1 summarizes demographic and screening mea-
sures. Within each age group there were no significant
differences in mean participant age between ApoE+ and
ApoE- participants (p >.05). Dementia Rating Scale
scores did not differ significantly between ApoE groups
or age groups (p >.05) and all participants’ DRS scores
were in the range of normal cognitive functioning. Ana-
lysis of odor threshold test performance revealed that all
participants scored in the normal range of olfactory
functioning. While all participants were normosmic, the
older participant group exhibited poorer olfactory
threshold scores than the middle and young age groups
(F(2,57) = 8.93, p <.001, η2 = .24), with no interaction of
ApoE status.
Odor and picture identification
Table 1 shows identification scores by age and ApoE
groups. Analysis of the San Diego Odor Identification
Test revealed no significant main effects or interaction
effects involving ApoE status (p >.05). It did demon-
strate a significant main effect of age (F(2,57) = 6.04,
p <.01, η2 = .18) with young participants correctly identi-
fying more odors than both the middle and older age
groups (p <.05).
Analysis of correctly identified number of odors from
the Odor Identification ERP task revealed a main effect
of ApoE status collapsed across age groups (F(1,54) =
4.54, p <.05) η2 = .08), such that ε4- participantscorrectly identified more odors than ε4+ participants.
The number of correctly identified odors did not differ
significantly by ApoE status when each age group was
analyzed separately, (suggesting that this effect is small
when the screening measures are applied). Analysis of
correctly identified pictures in the Picture Identification
ERP task revealed a significant main effect of age group
(F(2,54) = 3.60, p <.05, η2 = .12), such that older partici-
pants correctly identified more pictures than young par-
ticipants (p <.05). The effect of ApoE status was not
significant for Picture Identification.Topographical displays of ERP activity
Figure 1 illustrates topographical distributions of OERP
amplitudes in μV over the post-stimulus time interval
from 700 ms through 1300 ms by age and ApoE groups.
For each of 19 electrodes (FP1, FP2, F7, F3, F2, F4, F8,
T7, C3, CZ, C4, T8, P7, P3, P2, P4, P8, O1, O2) ampli-
tudes were averaged over the 100 ms time intervals (e.g.
700-800 ms) and input into graphing software in order
to visually display brain activity across the scalp for each
age and APOE group. Given no significant ApoE effects
in the visual modality only olfactory ERP topographies
are shown. In the young group the OERP topographical
maps show greater brain activation in the ε4+ partici-
pants compared to ε4- participants, over the left hemi-
sphere electrodes, and particularly over parietal
electrodes, that decreases after 1100 ms. Middle age ε4+
and ε4- individuals demonstrated similar topographies,
however ε4+ participants showed somewhat more activ-
ity over the right hemisphere electrodes compared to
left, in the 900-1100 ms range, whereas ε4- participants
showed more central electrode activity across the
recording epoch. The greatest differences can be
observed in the older groups where ε4- participants
showed an increase in activation over left and central
electrode sites between 900-1100 ms, and ε4+ partici-
pants showed relatively less overall activation during that
time period, but increasing activation over right frontal
electrodes between 1000-1200 ms. Overall the topo-
graphical maps clearly illustrate that brain activity
related to olfactory processing differs not only by age,
but more importantly by ApoE status, and the activity
differentially changes over the post-stimulus time period.Event Related Potentials (ERPs)
Repeated measures multivariate analyses of variance
(MANOVAs) were performed for each ERP component
(N1, P2, N2, P3) and olfactory and visual modalities
were analyzed separately for each peak amplitude and la-
tency. Greenhouse-Geisser corrections were applied to
all MANOVAs. Significant main effects and interactions
were further analyzed with post hoc Newman Keuls
Figure 1 Topographical representation of OERP amplitudes in μV across 19 electrode sites by age and ApoE groups for 700-1300 ms
post-stimulus time intervals.
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olfactory ERP effects are summarized in Table 2.
Picture identification ERPs
Visual N1, P2, and N2 amplitudes demonstrated no sig-
nificant main or interaction effects (p >.05). Visual P3
amplitude demonstrated a significant main effect for
electrode site (F(2,108) = 4.28, p <.05, η2 = .07) such that
the Cz and Pz electrode sites produced larger P3 ampli-
tudes than the Fz site.
Figure 2 illustrates visual ERP peak latencies. Visual
N1 and P2 latencies did not demonstrate significant
main or interaction effects (p >.05). Visual N2 latency
demonstrated a significant main effect of electrode site
(F(2,108) = 3.50, p <.05, η2 = .06) with the Pz electrode
site producing shorter N2 latencies than the Fz electrode
site. Visual P3 latency also revealed a significant main ef-
fect of electrode site (F(2,108) = 8.78, p <.01, η2 = .14)
with the Cz and Pz electrode sites recording significantly
longer latencies than the Fz site (p <.01). Visual P3 la-
tency also showed a significant main effect of age group
(F(2,54) = 4.94, p <.05, η2 = .15) with older adults produ-
cing significantly longer visual P3 latencies than young
adults (p <.01).
Odor identification ERPs
Olfactory N1, P2, and P3 amplitudes demonstrated no
significant main or interaction effects (p >.05). OlfactoryN2 amplitude demonstrated a significant main effect of
age (F(2,54) = 3.62, p <.05, η2 = .12) with older age parti-
cipants producing significantly more negative N2 ampli-
tudes than middle age participants.
Figure 2 illustrates olfactory ERP peak latencies.
Olfactory N1, P2, N2, and P3 latencies demonstrated
significant interaction effects of Age x ApoE status
(N1: F(2,54) = 4.73, p <.05, η2 = .15; P2: F(2,54) = 9.34,
p <.001, η2 = .26; N2: F(2,54) = 8.18, p <.01, η2 = .23; P3:
F(2,54) = 14.11, p <.001, η2 = .34). Post hoc analyses of
the interaction effects revealed that in the young group
those negative for the ε4 allele produced significantly
longer N2 (η2 = .26), and P3 (η2 = .29), latencies. In the
middle age group those positive for the ε4 allele pro-
duced significantly longer N1 (η2 = .31), and P2
(η2 = .31) latencies. In the older group those positive for
the ε4 allele produced significantly longer latencies for
all components N1 (η2 = .50), P2 (η2 = .52), N2(η2 = .35),
and P3(η2 = .59). For N1 and P3 latencies, in both
ApoE groups, older participants produced significantly
longer latencies than middle age participants and mid-
dle age participants produced longer latencies than
young participants. For P2 and N2 latencies in ε4+ par-
ticipants, this same pattern was observed, however in
ε4- participants young adults did not differ significantly
from middle age participants, but both young and mid-
dle age participants produced shorter latencies than
older participants.
Table 2 Summary of analyses performed and effect sizes for peak component amplitudes and latencies
Peak measures Amplitude Latency
N1 P2 N2 P3 N1 P2 N2 P3
Picture ID ERPs
Age (A) - - - - - - - *(η=.15)
ApoE Status (S) - - - - - - - -
Electrode (E) - - - *(η=.07) - - *(η=.06) *(η=.14)
A x S - - - - - - - -
A x E - - - - - - - -
S x E - - - - - - - -
A x S x E - - - - - - - -
Odor ID ERPs
Age (A) - - *(η=.12) - ***(η=.70) ***(η=.68) ***(η=.64) ***(η=.76)
ApoE Status (S) - - - - ***(η=.27) ***(η=.22) - -
Electrode (E) - - - - - - - -
A x S - - - - *(η=.15) ***(η=.26) **(η=.23) ***(η=.34)
A x E - - - - - - - -
S x E - - - - - - - -
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ERP odor ID performance and average (Fz, Cz, Pz) peak
latencies (N1, P2, N2, P3). When all ages and ApoE
groups were combined together odor ID performance
marginally correlated with N1 latency (r =−.28, p <.05).
Correlational analyses were also performed for each
age x ApoE group separately. The only significant correl-
ation between odor ID performance and latency was for
N1 latency in the older Apoe+ group (r =−.77, p <.01).
Logistic regression analyses of OERP variables
In order to better understand the predictive value of the
ERP in differentiating ε4- and ε4+ participants, stepwise
logistic regression analysis was performed on olfactory
N1, P2, N2, P3 amplitude and latency averaged over Fz,
Cz, and Pz. Visual ERP variables were not included in
logistic regression analysis because no significant ApoE
effects were present. A logistic regression is a type of re-
gression analysis used to predict the outcome of a binary
dependent variable (e.g. Apoe+ vs Apoe-) based on one
or more predictor variables (e.g. ERP amplitude and la-
tency). The logistic regression analysis outputs predictive
classification results including overall correct classifica-
tion (total percentage of correctly classified individuals),
as well as sensitivity (e.g. APOE+ correctly classified as
APOE+) and specificity (e.g. APOE- correctly classified
as APOE-). In the olfactory modality analysis of all age
groups combined revealed that olfactory N1 latency wasthe most significant single predictor in discriminating
between ε4+ participants and ε4- participants (χ2 = 6.07,
p <.05) resulting in an overall correct classification rate
of 70.0% (Sensitivity = 66.7%, Specificity = 73.3%). When
P3 latency was also added to N1 amplitude in the model
(χ2 = 8.06, p <.01) overall correct classification rate
increased to 76.7% (Sensitivity = 80%, Specificity =
73.3%). Logistic regressions were also performed for
each age group separately in order to better understand
the effects of ApoE status within each age group. In the
young participant group N2 amplitude was the most sig-
nificant predictor (χ2 = 7.79, p <.01) resulting in an over-
all classification rate of 65.0% (Sensitivity = 70.0%,
Specificity = 60.0%). In the middle age group P2 latency
was the most significant single predictor (χ2 = 6.86,
p <.01) resulting in an overall classification rate of 80.0%
(Sensitivity = 80.0%, Specificity = 80.0%). When P3 ampli-
tude and P3 latency were also added to the equation
with P2 latency (χ2 = 20.09, p <.001), the overall classifi-
cation rate for middle age participants increased to
90.0% (Sensitivity = 90.0%, Specificity = 90.0%). In the
older age group P3 latency was the most significant sin-
gle predictor (χ2 = 16.37, p <.001) resulting in an overall
classification rate of 90.0% (Sensitivity = 90.0%, Specifi-
city = 90.0%). When N1 latency was also added to the
equation with P3 latency (χ2 = 27.73, p <.001), overall
classification rate for older participants increased to
100.0% (Sensitivity = 100.0%, Specificity = 100.0%).
Figure 2 Visual and olfactory average N1, P2, N2, and P3 latencies by age and ApoE groups. Error bars represent the standard error of the
mean (SEM).
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This study demonstrated (1) robust odor identification
ERP differences based on ApoE status and interactions
with age; (2) high correct ApoE classification rates utiliz-
ing the OERP that were different for each age group.
A few previous studies have demonstrated ERP impair-
ments in persons with a positive family history of AD, in
those diagnosed with early AD, and in individuals with
mild cognitive impairment (MCI). MCI is commonly
defined as subtle but measurable memory impairment
without any other symptoms of dementia. Green et al.
[72] demonstrated auditory ERP P3 latency increases in
pre-clinical groups of persons with a family history of
AD and in those with a family history plus ε4+ status.
They did not indicate, however, how many of the partici-
pants demonstrated this latency difference, or how well
this measure correctly classified participants into ε4+ or
ε4- groups. Olichney et al. [73] studied participants diag-
nosed with MCI utilizing an N400/P600 semantic con-
gruency task and then tracked those participants over
time. Participants with abnormal N400 or P600 effects
had an 87 to 88% likelihood of progression to dementia
within 3 years. They suggest that these N400 abnormal-
ities in MCI may reflect subtle dysfunction of semantic
memory processes. Utilizing this method, classification
of participants into diagnostic groups was high in sensi-
tivity in MCI who converted to AD (81-94%) less so
when applied to all participants (58 to 65%). Chapman
et al. [74] used a visual number-letter memory task to
study ERPs in participants diagnosed as being in the
early stages of AD. Their results suggest that AD deficits
may include problems with storage in short-term mem-
ory, and that difficulties may lie in the cognitive proces-
sing of stimuli that are relevant to the task in which the
participant is engaged. Using this method the authors
were able to correctly classify 92% of participants into
AD or control groups. While these studies are extremely
helpful in understanding cognitive changes associated
with early stages of dementia, even at the MCI stage,
they also raise the possibility of early diagnosis at even
earlier, pre-MCI, pre-clinical, stages of AD. A measure
that would aid diagnosis of AD many years before any
manifestation of other signs or symptoms would be
ideal, especially once an effective medication for halting
or altering the dementing process is developed.
Illustrated on the ERP topographical maps, the current
study demonstrated differing patterns of brain activity
recorded over the scalp, depending on ApoE status.
fMRI studies on activation have reported mixed results,
with some showing increased activation in ε4 carriers
[30,75], and others demonstrating reduced activation in
ε4 carriers [76]. The current study demonstrates that
patterns of brain activation differ not only by ApoE sta-
tus, but across age groups, and that the pattern ofactivation changes across time over the post-stimulus
interval of cognitive processing. This suggests that pro-
cessing of olfactory stimuli is differentially affected by
presence or absence of the ε4 allele. Additionally these
effects change over the lifespan, such that individuals in
different decades of life, even young adults, show varying
patterns of brain activation.
In the present study, it is important to note that in
order to better understand the effects of the ApoE risk
factor at points before memory problems are present,
participants with dementia, early dementia, or mild cog-
nitive impairment, as well as those with anosmia or se-
vere hyposmia, were screened out of the study. Given
this rigorous screening process, it is not surprising that
no significant ApoE effects were found for the visual pic-
ture identification task. Very robust effects of ApoE sta-
tus were demonstrated for the odor identification ERP
task, as well as significant age by ApoE interaction
effects. This occurred despite no difference in perform-
ance on the Dementia Ratings Scale, odor threshold test-
ing, or the SDOIT by ApoE status. The present study
strongly suggests that combining olfactory processing
with cognitive processing [odor identification] may be
sensitive enough to differentiate very early those with a
high likelihood from those with a low likelihood of
developing AD, even as early as middle age. This to-
gether suggests the ability to identify odors and the
speed of odor identification is slowed in the presence of
the ε4 allele. Picture identification remained intact in
ApoE+ participants, both for number of pictures cor-
rectly identified and speed with which the pictures were
cognitively processed.
Of further note, the present study demonstrated good
ApoE classification rates of 80% in the middle age group,
with ε4+ participants producing significantly longer N1
and P2 latencies than ε4- participants. It suggests that
ApoE-related olfactory functional decline is taking place
at much earlier ages than previously observed, further
suggesting that early, pre-clinical, diagnosis of AD may
be a real possibility. Consistent with previous OERP
studies [62,63], older ε4+ participants produced signifi-
cantly longer OERP peak latencies. In this group 100%
classification rates were obtained suggesting a clear de-
lineation in performance between ε4+ and ε4- partici-
pants once they reach ages above 65 years old.
Further research needs to examine the utility of vari-
ous measures and tasks in the study of pre-clinical AD,
in order to capture the pre-dementing processes at the
earliest possible stages, and improve diagnostic ability.
Olfactory tasks involving cognitive processing, such as
the OERP, appear to be very promising in this regard.
Competing interest
The authors report no biomedical financial interests or potential conflicts of
interest.
Morgan and Murphy Behavioral and Brain Functions 2012, 8:37 Page 9 of 10
http://www.behavioralandbrainfunctions.com/content/8/1/37Authors’ contributions
CDM and CM designed the study and advised the research assistants
through data collection and analysis, and interpreted the data. CDM
constructed the olfactometer. CDM and CM wrote and approved the final
version of the manuscript.
Acknowledgments
Supported by NIH Grant DC002064 to Claire Murphy. The authors would like
to thank the late Dr. Leon Thal and the UCSD ADRC (P50AG005131-28) for
genotyping, Dr. John Polich, Krystin Corby, Joel Kowalewski, Jessica
Bartholow, and Roberto Zamora for research assistance.
Author details
1Department of Psychology, San Diego State University, San Diego, CA
92120, USA. 2University of California San Diego Medical Center, San Diego,
CA 92120, USA. 3SDSU/UCSD Joint Doctoral Program, 6363 Alvarado Ct.,
Suite 101, San Diego, CA 92120-4913, USA.
Received: 22 January 2012 Accepted: 15 June 2012
Published: 31 July 2012
References
1. American Psychiatric Association: Diagnostic and statistical manual of mental
disorders, Revised 4th ed. Washington, DC: American Psychiatric Press; 2000.
2. Blacker D: The genetics of Alzheimer's disease: progress, possibilities, and
pitfalls. Harv Rev Psychiatry 1997, 5(4):234–237.
3. Combarros O, Alvarez-Arcaya A, Sanchez-Guerra M, Infante J, Berciano J:
Candidate gene association studies in sporadic Alzheimer's disease.
Dement Geriatr Cogn Disord 2002, 14(1):41–54.
4. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small
GW, Roses AD, Haines JL, Pericakvance MA: Gene dose of apolipoprotein E
type 4 allele and the risk of Alzheimer's disease in late onset families.
Science 1993, 261(5123):921–923.
5. Teter B, Raber J, Nathan B, Crutcher KA: The presence of apoE4, not the
absence of apoE3, contributes to AD pathology. J Alzheimers Dis 2002,
4:155–163.
6. Bertram L, Tanzi RE: The genetic epidemiology of neurodegenerative
disease. J Clin Invest 2005, 115(6):1449–1457.
7. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH,
Pericakvance MA, Risch N, vanDuijn CM: Effects of age, sex, and ethnicity
on the association between apolipoprotein E genotype and Alzheimer
disease - A meta-analysis. JAMA 1997, 278(16):1349–1356.
8. Burke W, Pinsky LE, Press NA: Categorizing genetic tests to identify
their ethical, legal, and social implications. Am J Med Genet 2001,
106(3):233–240.
9. Murphy C: Loss of olfactory function in dementing disease. Physiol Behav
1999, 66(2):177–182.
10. Averback P: 2 new lesions in Alzheimers-disease. Lancet 1983,
2(8360):1203.
11. Braak H, Braak E: Frequency of stages of Alzheimer-related lesions in
different age categories. Neurobiol Aging 1997, 18:351–357.
12. Christen-Zaech S, Kraftsik R, Pillevuit O, Kiraly M, Martins R, Khalili K, Miklossy
J: Early olfactory involvement in Alzheimer's disease. Can J Neurol Sci
2003, 30(1):20–25.
13. Esiri MM, Wilcock GK: The Olfactory bulbs in Alzheimers-disease. J Neurol
Neurosurg Psychiatry 1984, 47(1):56–60.
14. Ohm TG, Braak H: Olfactory-Bulb Changes in Alzheimers-Disease. Acta
Neuropathol 1987, 73(4):365–369.
15. Reyes PF, Golden GT, Fariello RG, Fagel L, Zalewska M: Olfactory pathways
in Alzheimer's disease (AD): Neuropathological studies [abstract]. Society
for Neuroscience 1985, 11:168.
16. Van Hoesen GW, Solodkin A: Cellular and systems neuroanatomical
changes in Alzheimer's disease. In: Calcium hypothesis of aging and
dementia. Disterhoft JF, Khachaturian ZS (eds). Proc NY Acad Sci (USA)
1994, 747:12–35.
17. den Heijer T, Oudkerk M, Launer LJ, Van Duijn CM, Hofman A, Breteler MM:
Hippocampal, amygdalar, and global brain atrophy in different
apolipoprotein E genotypes. Neurology 2002, 59:746–748.
18. Murphy C, Bacon AW, Bondi MW, Salmon DP: Apolipoprotein E status is
associated with odor identification deficits in nondemented older
persons. Ann N Y Acad Sci 1998, 855:744–750.19. Bacon AW, Bondi MW, Salmon DP, Murphy C: Very early changes in
olfactory functioning due to Alzheimer's disease and the role of
apolipoprotein E in olfaction. Ann N Y Acad Sci 1998, 855:723–731.
20. Schiffman SS, Graham BG, Sattely-Miller EA, Zervakis J, Welsh-Bohmer K:
Taste, smell and neuropsychological performance of individuals at
familial risk for Alzheimer's disease. Neurobiol Aging 2002, 23(3):397–404.
21. Gilbert PE, Murphy C: Differences between recognition memory and
remote memory for olfactory and visual stimuli in nondemented elderly
individuals genetically at risk for Alzheimer's disease. Exp Gerontol 2004,
39(3):433–441.
22. Morgan CD, Nordin S, Murphy C: Odor Identification as an Early Marker
for Alzheimers-Disease - Impact of Lexical Functioning and Detection
Sensitivity. J Clin Exp Neuropsychol 1995, 17(5):793–803.
23. Olofsson JK, Nordin S, Wiens S, Hedner M, Nilsson LG, Larsson M: Odor
identification impairment in carriers of ApoE-varepsilon4 is independent
of clinical dementia. Neurobiol Aging 2010, 31(4):567–577.
24. Calhoun-Haney R, Murphy C: Apolipoprotein epsilon 4 is associated with
more rapid decline in odor identification than in odor threshold or
Dementia Rating Scale scores. Brain Cogn 2005, 58(2):178–182.
25. Murphy C, Jernigan TL, Fennema-Notestine C: Left hippocampal volume loss
in Alzheimer's disease is reflected in performance on odor identification: a
structural MRI study. J Int Neuropsychol Soc 2003, 9(3):459–471.
26. Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett DA:
Olfactory Impairment in Presymptomatic Alzheimer's Disease. Ann N Y
Aca Sci 2009, 1170(1):730–735(736).
27. Backman L, Andersson JL, Lyberg L, Winblad B, Nordberg A, Almkvist O:
Brain regions associated with episodic retrieval in normal aging and
Alzheimer's disease. Neurology 1999, 52(9):1861–1870.
28. Becker JT, Mintun MA, Aleva K, Wiseman MB, Nichols T, DeKosky ST:
Compensatory reallocation of brain resources supporting verbal episodic
memory in Alzheimer's disease. Neurology 1996, 46(3):692–700.
29. Bondi MW, Houston WS, Eyler LT, Brown GG: fMRI evidence of
compensatory mechanisms in older adults at genetic risk for Alzheimer
disease. Neurology 2005, 64(3):501–508.
30. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA,
Mazziotta JC, Small GW: Patterns of brain activation in people at risk for
Alzheimer's disease. N Engl J Med 2000, 343(7):450–456.
31. Grady CL, McIntosh AR, Beig S, Keightley ML, Burian H, Black SE: Evidence
from functional neuroimaging of a compensatory prefrontal network in
Alzheimer's disease. J Neurosci 2003, 23(3):986–993.
32. Saykin AJ, Flashman LA, Frutiger SA, Johnson SC, Mamourian AC, Moritz CH,
O’Jile JR, Riordan HJ, Santulli RB, Smith CA, Weaver JB: Neuroanatomic
substrates of semantic memory impairment in Alzheimer's disease:
patterns of functional MRI activation. J Int Neuropscyhol Soc 1999,
5(5):377–392.
33. Woodard JL, Grafton ST, Votaw JR, Green RC, Dobraski ME, Hoffman JM:
Compensatory recruitment of neural resources during overt rehearsal of
word lists in Alzheimer's disease. Neuropsychology 1998, 12(4):491–504.
34. Seidenberg M, Guidotti L, Nielson KA, Woodard JL, Durgerian S, Antuono P,
Zhang Q, Rao SM: Semantic memory activation in individuals at risk for
developing Alzheimer disease. Neurology 2009, 73(8):612–620.
35. Rombouts SA, Barkhof F, van Meel CS, Scheltens P: Alterations in brain
activation during cholinergic enhancement with rivastigmine in
Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002, 73(6):665–671.
36. Covington JW, Geisler MW, Polich J, Murphy C: Normal aging and odor
intensity effects on the olfactory event-related potential. Int J
Psychophysiol 1999, 32(3):205–214.
37. Evans WJ, Cui L, Starr A: Olfactory event-related potentials in normal
human subjects: effects of age and gender. Electroencephalogr Clin
Neurophysiol 1995, 95(4):293–301.
38. Morgan CD, Covington JW, Geisler MW, Polich J, Murphy C: Olfactory
event-related potentials: older males demonstrate the greatest deficits.
Electroencephalogr Clin Neurophysiol 1997, 104(4):351–358.
39. Morgan CD, Geisler MW, Covington JW, Polich J, Murphy C: Olfactory P3 in
young and older adults. Psychophysiology 1999, 36(3):281–287.
40. Morgan CD, Murphy C: Differential effects of active attention and age on
event-related potentials to visual and olfactory stimuli. Int J Psychophysiol
2010, 78(2):190–199.
41. Murphy C, Morgan CD, Geisler MW, Wetter S, Covington JW, Madowitz MD,
Nordin S, Polich JM: Olfactory event-related potentials and aging:
normative data. Int J Psychophysiol 2000, 36(2):133–145.
Morgan and Murphy Behavioral and Brain Functions 2012, 8:37 Page 10 of 10
http://www.behavioralandbrainfunctions.com/content/8/1/3742. Nordin S, Quinonez C, Morgan CD, Geisler MW, Polich J, Murphy C:
Olfactory event-related potentials in young and elderly adults:
evaluation of tracking task versus eyes open/closed recording. Chem
Senses 1999, 24(4):459–464.
43. Thesen T, Wetter S, Murphy C: Olfactory event-related potential detects
age-related changes in olfactory processing with velopharyngeal closure
and normal breathing. Psychophysiology 2000, 37:S97.
44. Wetter S, Murphy C: Individuals with Down's syndrome demonstrate
abnormal olfactory event-related potentials. Clin Neurophysiol 1999,
110(9):1563–1569.
45. Wetter S, Peavy G, Jacobson M, Hamilton J, Salmon D, Murphy C: Olfactory
and auditory event-related potentials in Huntington's disease.
Neuropsychology 2005, 19(4):428–436.
46. Kobal G: Elektrophysiologische Untersuchungen des menschlichen Geruchsinns.
Stuttgart: Thieme; 1981.
47. Lorig TS, Elmes DG, Zald DH, Pardo JV: A computer-controlled
olfactometer for fMRI and electrophysiological studies of olfaction. Behav
Res Methods Instrum Comput 1999, 31(2):370–375.
48. Lorig TS: The application of electroencephalographic techniques to the
study of human olfaction: a review and tutorial. Int J Psychophysiol 2000,
36(2):91–104.
49. Murphy C, Nordin S, de Wijk RA, Cain WS, Polich J: Olfactory-evoked
potentials: assessment of young and elderly, and comparison to
psychophysical threshold. Chem Senses 1994, 19(1):47–56.
50. Overbosch P, de Wijk R, de Jonge TJ, Koster EP: Temporal integration and
reaction times in human smell. Physiol Behav 1989, 45(3):615–626.
51. Ekman GB, Berglund U, Berglund B, Lindwall T: Perceived intensity of odor:
a function of time of adaptation. Scan J Psychol 1967, 8:177–186.
52. Wilson DA, Linster C: Neurobiology of simple memory. J Neurophysiol
2008, 100:2–7.
53. Polich J: P300, probability, and inter-stimulus interval. Psychophysiology
1990, 27:396–403.
54. Polich J: Probability and inter-stimulus interval effects on the P300 from
auditory stimuli. Int J Psychophysiol 1990, 10:163–170.
55. Polich J: P300 in clinical applications: meaning, method, and
measurement. In Electroencephalography: Basic Principles, Clinical
Applications, and Related Fields. 3rd edition. Edited by Niedermeyer E, Lopes
da Silva F. Baltimore, MD: Williams and Wilkins; 1993:1005–1018.
56. Moore PA: A model of the role of adaptation and disadaptation in
olfactory receptor neurons: implications for the coding of temporal and
intensity patterns in odor signals. Chem Senses 1994, 19(1):17–86.
57. Murphy C, Morgan CD: Olfactory Function and Event-Related Potentials in
Alzheimers Disease. In Alzheimer’s Disease: Advances in Etiology,
Pathogenesis and Therapeutics. Edited by Iqbal K, Sisodia SS, Winblad B.
Chichester, UK: John Wiley and Sons, Ltd; 2001:237–251.
58. Donchin E, Heffley E, Hillyard SA, Loveless N, Maltzman I, Ohman A, Rosler F,
Ruchkin D, Siddle D: Cognition and event-related potentials. II. The
orienting reflex and P300. Ann N Y Acad Sci 1984, 425:39–57.
59. Polich J, Hoffman LD: P300 and handedness: on the possible contribution
of corpus callosal size to ERPs. Psychophysiology 1993, 35(5):497–507.
60. Geisler MW, Morgan CD, Covington JW, Murphy C: Neuropsychological
performance and cognitive olfactory event-related brain potentials in
young and elderly adults. J Clin Exp Neuropsychol 1999, 21(1):108–126.
61. Morgan CD, Murphy C: Olfactory event-related potentials in Alzheimer's
disease. J Int Neuropsychol Soc 2002, 8(6):753–763.
62. Wetter S, Murphy C: Apolipoprotein E epsilon 4 positive individuals
demonstrate delayed olfactory event-related potentials. Neurobiol Aging
2001, 22(3):439–447.
63. Murphy C, Solomon ES, Haase L, Wang M, Morgan CD: Olfaction in aging
and Alzheimer's disease: event-related potentials to a cross-modal odor-
recognition memory task discriminate ApoE epsilon4+ and ApoE epsilon
4- individuals. Ann N Y Acad Sci 2009, 1170:647–657.
64. Cain WS, Gent J, Catalanotto FA, Goodspeed RB: Clinical evaluation of
olfaction. Am J Otolaryngol 1983, 4(4):252–256.
65. Murphy C, Gilmore MM, Seery CS, Salmon DP, Lasker BR: Olfactory
thresholds are associated with degree of dementia in Alzheimer's
disease. Neurobiol Aging 1990, 11(4):465–469.
66. Mattis S: Mental status examination for organic mental syndrome in the
elderly patient. In Geriatric psychiatry: A handbook for psychiatrists and
primary care physicians. Edited by Bellak L, Katasu TB. New York: Grune and
Statton; 1976:77–121.67. Sundermann EE, Gilbert PE, Murphy C: Apolipoprotein E epsilon 4
genotype and gender: Effects on memory. Am J Geriatr Psychiatry 2007,
15(10):869–878.
68. Zamora R, Bartholow J, Green E, Morgan CD, Murphy C: Adiposity
measures predict olfactory processing speed in older adult carriers of
the apolipoprotein E4 allele. Clin Neurophysiol 2011, doi:10.1016/j.
clinph.2011.09.001.
69. Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM:
Prevalence of olfactory impairment in older adults. JAMA 2002,
288(18):2307–2312.
70. Thesen T, Murphy C: Age-related changes in olfactory processing
detected with olfactory event-related brain potentials using
velopharyngeal closure and natural breathing. Int J Psychophysiol 2001,
40(2):119–127.
71. Kaplan E, Goodglass H, Weintrab S: The Boston Naming Test. Philadelphia:
Lea and Febiger; 1983.
72. Green J, Levey AI: Event-related potential changes in groups at increased
risk for Alzheimer disease. Arch Neurol 1999, 56(11):1398–1403.
73. Olichney JM, Taylor JR, Gatherwright J, Salmon DP, Bressler AJ, Kutas M, Iragui-
Madoz VJ: Patients with MCI and N400 or P600 abnormalities are at very
high risk for conversion to dementia. Neurology 2008, 70(19):1763–1770.
74. Chapman RM, Nowlis GH, McCrary JW, Chapman JA, Sandoval TC, Guillily
MD, Gardner MN, Reilly LA: Brain event-related potentials: diagnosing
early-stage Alzheimer's disease. Neurobiol Aging 2007, 28(2):194–201.
75. Han SD, Houston WS, Jak AJ, Eyler LT, Nagel BJ, Fleisher AS, Brown GG,
Cory-Bloom J, Salmon D, Thal LJ, Bondi MW: Verbal paired-associate
learning by APOE genotype in non-demented older adults: fMRI
evidence of a right hemispheric compensatory response. Neurobiol Aging
2007, 28(2):238–247.
76. Lind J, Persson J, Ingvar M, Larsson A, Cruts M, Van Broeckhoven C,
Adolfsson R, Backman L, Nilsson LG, Petersson KM, Nyberg L: Reduced
functional brain activity response in cognitively intact apolipoprotein E
epsilon 4 carriers. Brain 2006, 129:1240–1248.
doi:10.1186/1744-9081-8-37
Cite this article as: Morgan and Murphy: Individuals at risk for
Alzheimer’s disease show differential patterns of ERP brain activation
during odor identification. Behavioral and Brain Functions 2012 8:37.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
